. Author manuscript; available in PMC: 2014 Jun 14.

Published in final edited form as: Curr HIV Res. 2012 Jul;10(5):463–468. doi: 10.2174/157016212802138715

Table 1.

ANOVA P-values for WT versus TG Hippocampal Parvalbumin+ Neuron Cell Density Measurements for the Dietary and Morphine Treatment Groups

	WT ND PLA	WT ND MOR	WT VA PLA	WT VA MOR	TG ND PLA	TG ND MOR	TG VA PLA	TG VA MOR
WT ND PLA			0.001 (2392)	0.001 (−1626)			0.001 (2303)
WT ND MOR			0.001 (1749)	0.001 (969.2)			0.001 (1660)
WT VA PLA	0.001 (−2392)	0.001 (−1749)		0.01 (−765.7)	0.001 (−1936)	0.001 (−1735)		0.001 (−1598)
WT VA MOR	0.001 (1626)	0.001 (−969.2)	0.01 (765.7)		0.001 (−1170)		0.01 (676.6)	0.01 (−832.3)
TG ND PLA			0.001 (1936)	0.001 (1170)			0.001 (1846)
TG ND MOR			0.001 (1735)				0.001 (1646)
TG VA PLA	0.001 (−2303)	0.001 (−1660)		0.01 (−676.6)	0.001 (−1846)	0.001 (−1646)		0.001 (−1509)
TG VA MOR			0.001 (1598)	0.01 (832.3)			0.001 (1509)

Value in parentheses = mean difference between the comparison groups.

Gray boxes represent comparisons that were not statistically significant